Listed

Kraig Biocraft Laboratories, Inc.: Form 10-K for the period ended Dec 31, 2012

Filed with the SEC on Apr 15, 2013 and accepted by EDGAR at Apr 15, 2013, 16:38 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2012-01-01 to 2012-12-31$0us-gaap:SalesRevenueNet
Research and development12 months2012-01-01 to 2012-12-31$465.3kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2012-01-01 to 2012-12-31−$1.2mus-gaap:OperatingIncomeLoss
Interest expense12 months2012-01-01 to 2012-12-31$45.7kus-gaap:InterestExpense
Income tax12 months2012-01-01 to 2012-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2012-01-01 to 2012-12-31−$1.2mus-gaap:NetIncomeLoss
Diluted EPS12 months2012-01-01 to 2012-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2012-01-01 to 2012-12-31−$562.9kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2012-01-01 to 2012-12-31$0us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-12-31$53.8kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-12-31$62.2kus-gaap:AssetsCurrent
Total assetsAt period end2012-12-31$78.8kus-gaap:Assets
Current liabilitiesAt period end2012-12-31$1.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-12-31$1.2mus-gaap:Liabilities
Long-term debtAt period end2012-12-31$8.8kus-gaap:LongTermDebt
Shareholders' equityAt period end2012-12-31−$1.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-13-001972. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.